Page last updated: 2024-12-06

tri-n-butylmethylammonium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

tri-n-butylmethylammonium: RN given refers to iodide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID76521
SCHEMBL ID239485
MeSH IDM0128730

Synonyms (24)

Synonym
tri-n-butylmethylammonium
nsc 136982
einecs 221-402-4
methyltributylammonium iodide
3085-79-8
nsc-136982
nsc136982
tributylmethylammonium iodide
n,n-dibutyl-n-methylbutan-1-aminium iodide
tributyl(methyl)azanium iodide
AKOS024319169
FT-0634652
SCHEMBL239485
T3692
DTXSID8091534
mfcd00031623
n-tributyl-n-methylammonium iodide
AS-68760
tri-n-butylmethyl ammonium iodide
tributyl(methyl)azanium;iodide
n-tributyl-n-methylammonium iodide 98%
D92734
1-butanaminium, n,n-dibutyl-n-methyl-, iodide (1:1)
CS-0362416

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The oral bioavailability of tributylmethyl ammonium (TBuMA), an organic cation (OC), exhibited a dose-dependency (i."( Dose dependency in the oral bioavailability of an organic cation model, tributylmethyl ammonium (TBuMA), in rats: association with the saturation of efflux by the P-gp system on the apical membrane of the intestinal epithelium.
Choi, MK; Chung, SJ; Han, L; Han, YH; Kim, DD; Kim, MK; Shim, CK, 2005
)
0.33
"0 micormole x min/L for iv and oral administration, indicating a lower oral bioavailability of TBuMA (35."( Mechanism of intestinal transport of an organic cation, tributylmethylammonium in Caco-2 cell monolayers.
Hong, SS; Moon, SC; Shim, CK, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.67)18.7374
1990's13 (43.33)18.2507
2000's13 (43.33)29.6817
2010's2 (6.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]